Trailing-twelve-month (TTM) revenue is $14.13 Billion with a year-over-year growth of (3.94%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-10-03 | $3,925,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-25 |
| Q1 FY2026Period ended 2026-01-02 | $3,237,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-10 |
| Q2 FY2026Period ended 2026-04-03 | $3,478,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q3 FY2026Period ended 2026-07-03 | $3,490,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-11 |
| TTM revenue | $14,130,000,000 |
Current P/S: $4,811,020,680 market capitalization ÷ $14,130,000,000 TTM revenue = 0.34x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T20:00:02.000Z. Latest revenue period ended 2026-07-03.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-07-03): $3.49B.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 11 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T22:50:17.871Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-09-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-09-27 · USD |
|---|---|
| Non-US | $2.3B |
| UNITED STATES | $6.1B |
$14.13B
$14.13 Billion
(3.94%)
vs. $14.71B a year ago (TTM)
+23.24%
3 Year compound annual growth rate
1 Year
(3.94%)
3 Year
+23.24%
5 Year
N/A
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $14.39B | +$6.00B | +71.59% |
| 2024 | $8.39B | +$523.00M | +6.65% |
| 2023 | $7.87B | +$189.00M | +2.46% |
| 2022 | $7.68B | +$2.58B | +50.75% |
TTM Growth
(3.94%)
3-Year CAGR
+23.24%
5-Year CAGR
N/A
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T22:50:17.871Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
